Evidence map›Paper›PMID 38379956›Full record

ArticleFrontiers in cellular and infection microbiology2023

Deciphering complex antibiotic resistance patterns in

Jianwei Yu, Yan Jia, Qichao Yu, Lan Lin, Chao Li, Bowang Chen, Pingyu Zhong, Xueqing Lin, Huilan Li, Yinping Sun and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Jianwei Yu *Department of Gastroenterology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
Yan Jia *Department of Gastroenterology, the 7Medical Center of PLA General Hospital, Beijing, China.
Qichao Yu *Center for Systems Biology, Intelliphecy, Main Building, Beishan Industrial Zone, Shenzhen, Guangdong, China.
Lan Lin *Department of Gastroenterology, Xiamen Humanity Hospital, Xiamen, Fujian, China.
Chao LiDepartment of Gastroenterology, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Bowang ChenCenter for Systems Biology, Intelliphecy, Main Building, Beishan Industrial Zone, Shenzhen, Guangdong, China.
Pingyu ZhongDepartment of Gastroenterology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
Xueqing LinDepartment of Gastroenterology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
Huilan LiDepartment of Nephrology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
Yinping SunDepartment of Gastroenterology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
Xuejing ZhongDepartment of Science and Education, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
Yuqi HeDepartment of Gastroenterology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Xiaoyun HuangCenter for Systems Biology, Intelliphecy, Main Building, Beishan Industrial Zone, Shenzhen, Guangdong, China.
Shuangming LinDepartment of Gastrointestinal Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
Yuanming PanCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
First Affiliated Hospital of Fujian Medical University · CNFujian Medical University · CNBeijing Chest Hospital · CNCapital Medical University · CNChinese PLA General Hospital · CNPeking University · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Helicobacter pylori (H.pylori, Hp) affects billions of people worldwide. However, the emerging resistance of Hp to antibiotics challenges the effectiveness of current treatments. Investigating the genotype-phenotype connection for Hp using next-generation sequencing could enhance our understanding of this resistance. Methods: In this study, we analyzed 52 Hp strains collected from various hospitals. The susceptibility of these strains to five antibiotics was assessed using the agar dilution assay. Whole-genome sequencing was then performed to screen the antimicrobial resistance (AMR) genotypes of these Hp strains. To model the relationship between drug resistance and genotype, we employed univariate statistical tests, unsupervised machine learning, and supervised machine learning techniques, including the development of support vector machine models. Results: Our models for predicting Amoxicillin resistance demonstrated 66% sensitivity and 100% specificity, while those for Clarithromycin resistance showed 100% sensitivity and 100% specificity. These results outperformed the known resistance sites for Amoxicillin (A1834G) and Clarithromycin (A2147), which had sensitivities of 22.2% and 87%, and specificities of 100% and 96%, respectively. Discussion: Our study demonstrates that predictive modeling using supervised learning algorithms with feature selection can yield diagnostic models with higher predictive power compared to models relying on single single-nucleotide polymorphism (SNP) sites. This approach significantly contributes to enhancing the precision and effectiveness of antibiotic treatment strategies for Hp infections. The application of whole-genome sequencing for Hp presents a promising pathway for advancing personalized medicine in this context.

Indexed as

Helicobacter InfectionsHelicobacter pyloriAmoxicillinAnti-Bacterial AgentsClarithromycinDrug Resistance, BacterialDrug Resistance, MicrobialHumansMachine LearningMicrobial Sensitivity TestsWhole Genome SequencingAmoxicillinAnti-Bacterial AgentsClarithromycinantimicrobial resistance (AMR)genomic sequencing dataHelicobactor pylorimachine learning methodsmolecular mechanism

Identifiers

PMID38379956
PMCPMC10878306
OpenAlexW4390584270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.